language US | EN expand_more News Events Investor Relations Careers menu Menu Search search Industry Sektor Life Sciences Willis Towers Watson is a leading risk and insurance management firm to the life science industry with over 600 life science clients worldwide. With offices in 120 countries, we serve the global needs of our clients no matter where they conduct business. Share share Jump navigation The following links will skip the user to important content areas of the page Our expertise How we serve our clients Regulatory information What makes us different We help a broad spectrum of life science companies to mitigate threats and create opportunities across a wide range of risk and human capital issues. Life science businesses operate in highly regulated and fast developing environments and across geographies. Willis Towers Watson has the knowledge and dedicated resources to help life science companies navigate this complex risk landscape. We understand the challenges faced by the industry and have the experience and expertise to enable you to make the best decisions and implement the right solutions to manage your risk and people. Our investment in technical expertise benefits our clients every day. Our teams comprise a cross-section of professional backgrounds and credentials, including professionals with backgrounds as scientists, attorneys, risk managers, brokers, underwriters, risk engineers and claims specialists. Our global footprint and multinational knowledge allows us to anticipate trends and regulations around the world and afford easy access to relevant information about any location in which our clients do business. There is no substitute for responsiveness, innovation, broking excellence and program delivery. 200 Life Science practitioners at Willis Towers Watson 600+ clients ranging from large multinational companies to early stage start-ups 1000+ clinical trials placed globally Our expertise We specialize in services for: Pharmaceutical and biotech Therapeutic research and development Generic/specialty drug manufacturers Medical device/digital health companies Contract research organizations (CRO) Contract manufacturing organizations (CMO) Diagnostic laboratories Nutraceutical and over-the-counter (OTC) We have a globally integrated practice with industry specialists in all aspects of client service including: Property and casualty Clinical trials Claims advocacy Management liability Risk and loss control Cyber Analytical tools Mergers and acquisitions (M&A) due diligence How we serve our clients We provide a service with traditional values, advice and relationships you can trust. Before we place any insurance, we work with you to identify and quantify your risks to ensure the most efficient protection for your balance sheet. We provide you with the confidence that your insurance programs are created to fit your specific needs. For all our clients, we challenge the status quo and create programs that will evolve as they do. Due to a fast-paced and constantly evolving risk environment, we help you to anticipate risks and plan mitigation strategies for the next development. We guard the present with an eye on the future. We offer you a single point of access, aligning specialist teams across every line of coverage. Using a proprietary client portal ensures real-time access to risk information facilitating efficient and proactive decision-making. The majority of our life science clients do not have a risk manager. This reality has prompted us to build a service model for every client designed to optimise resources whilst improving outcomes. Access to global regulatory information We have access to global regulatory and compliance information via our online database used extensively across our global network to ensure we’re keeping our clients informed with the most up to date developments. This information is provided by country and includes: Non-admitted status In-country regulations Insurance limits Professional liability requirements Certiﬁcate protocols Speciﬁc information requirements for each country What makes us different We provide our clients with regular in-depth trends and insights on emerging risks impacting the life sciences industry and insurance marketplace to help them implement the right solutions for their organization. Our advanced loss modelling capabilities. Connected Risk Intelligence is an innovative development in risk consulting which visualises risk in a single language and framework to empower organizations to make better risk finance decisions. At Willis Towers Watson, we spend the time evaluating and analysing your risk exposures in order to help minimize the total cost of risk. As well as supporting you achieve your organization’s goals. We provide direction and consultation on risk mitigation strategies and improvement opportunities to help enhance your organization’s performance. We offer a range of solutions to address your people, risk and capital issues. Our service team offers access to specialists who are life science experts in areas in different lines of business including: directors and officers liability, cyber, product liability, supply chain, cargo, assets and risk engineering. Downloads Title File Type File Size D&O for publicly traded life sciences companies 2020 – COVID-19 Update PDF .6 MB PREP Act – COVID-19 PDF .4 MB Life sciences PDF .3 MB Featured Event Life Science Webinar Series: Future-proofing your life science business Thursday 2 December 2021 Register now keyboard_arrow_right Contacts John Connolly North American Practice Leader – Life Sciences Email | +1 610 254 5686 Sandie Mullen North American Broking Leader Life Sciences Email | +1 913 563 8853 Related Content Article Life Sciences insurance marketplace realities Article Using AI to augment a digital operating model in the post-pandemic world Related Capabilities Property Casualty Clinical trials insurance Financial, Executive and Professional Risks (FINEX) Cargo Non damage business interruption insurance for life sciences companies Cargo insurance solution for life science companies Related Insights See All Insights keyboard_arrow_right Article Cell and gene therapies: managing risk at the frontiers of life science Article Trends on equity provisions in biopharma de-SPAC transactions Article D&O for publicly traded life science companies 2021 White Paper Digital Health Big Data Risks keyboard_arrow_left 1 2 3 keyboard_arrow_right Contact Us About Us People Risk Capital News Insights Events Investor Relations Careers Office Locations Social Media Contact Us Sitemap Global Website Privacy Notice Terms of Use Accessibility Statement Cookie Notice Cookie Preferences Code of Conduct Do Not Sell My Personal Information Copyright © 2021 Willis Towers Watson. All rights reserved.